• Rovia Clinical Research acquired Pinnacle Research Group in Anniston, Alabama, and Cullman Clinical Trials in Cullman, Alabama.
• The deals expand Rovia’s clinical research site network in Alabama, adding capabilities in cardiometabolic health and Phase I programs.
• Gauge Capital partner David Friedman cited continued growth momentum for the Rovia platform.
• Rovia operates 20 locations across eight states, pursuing further expansion through acquisitions and partnerships.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gauge Capital LLC published the original content used to generate this news brief on September 15, 2026, and is solely responsible for the information contained therein.